The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.
The Metamorphosis of Clinical Trials: Evolving Roles of Stakeholders in Digital Trials
Josh Rose, MBA
Vice President, Global Head of Strategy
IQVIA, United States
This session will examine the promise of virtual trials to address challenges of traditional site-based models by examining the evolving roles of study stakeholders, patients, investigators, and study managers, and how they improve study performance
Learning Objective : Describe the potential promise, benefits, and considerations of virtual clinical trials to address challenges to clinical trial conduct and participation; Define the evolution of stakeholder roles, existing and new, and the interplay between them, in virtual/direct to patient clinical trials; Apply insights to inform virtual trial design and planning.
Angela Botto-van Bemden, PhD
Director, OA Programs
Arthritis Foundation, United States
Murray Alexander Abramson, DrMed, MPH
Vice President, Global Clinical Operations
Biogen Inc., United States
Jeff Kingsley, DO, MBA
Cheif Executive Officer
IACT Health, United States